SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page7891011121314Next Page
2026-04-30ELVN144Lyssikatos Joseph P plan to sell securities of Enliven Therapeutics, Inc. under Form 144MEDIUM
Lyssikatos Joseph P filed Form 144 to notify SEC of plan to sell 25000 units of Enliven Therapeutics, Inc. securities around 2026-04-30, with aggregate market value of $1,060,000.00. The total outstanding units is 59000000.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions...
Mid CapBiotechnology
Previous Page7891011121314Next Page